Drugs & Therapy Perspectives

, Volume 10, Issue 6, pp 12–16 | Cite as

Economics a secondary consideration in serious childhood infections

Drug Economics and Quality of Life


Adis International Limited Sudden Cardiac Death Infective Endocarditis Bacterial Meningitis Teicoplanin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hoppe JE. Rational prescribing of antibacterials in hospitalised children. Pharmacoeconomics 1996; 10(6): 575–93PubMedCrossRefGoogle Scholar
  2. 2.
    Hoppe JE. Rational prescribing of antibacterials in ambulatory children. Pharmacoeconomics 1996; 10(6): 552–74PubMedCrossRefGoogle Scholar
  3. 3.
    Fleisher GR, Rosenberg N, Vinci R, et al. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J Pediatr 1994; 124: 504–12PubMedCrossRefGoogle Scholar
  4. 4.
    Bass JW, Steele RW, Wittler RR, et al. Antimicrobial treatment of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis J 1993; 12: 466–73PubMedCrossRefGoogle Scholar
  5. 5.
    Klugman KP, Dagan R. Carbapenem treatment of meningitis. Scand J Infect Dis 1995; Suppl. 96: 45–8Google Scholar
  6. 6.
    O’Neill P. How long to treat bacterial meningitis. Lancet 1993; 341: 530PubMedCrossRefGoogle Scholar
  7. 7.
    Powell KP, Mawhorter SD. Outpatient treatment of serious infections in infants and children with ceftriaxone. J Pediatr 1987; 110: 898–901PubMedCrossRefGoogle Scholar
  8. 8.
    Lieu TA, Schwartz JS, Jaffe DM, et al. Strategies for diagnosis and treatment of children at risk for occult bacteraemia: clinical effectiveness and cost-effectiveness. J Pediatr 1991; 118: 21–9PubMedCrossRefGoogle Scholar
  9. 9.
    Starke JR. Infective endocarditis. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. Philadelphia: WB Saunders, 1992: 326–43Google Scholar
  10. 10.
    Baltimore RS. Infective endocarditis in children. Pediatr Infect Dis J 1992; 11: 907–12PubMedCrossRefGoogle Scholar
  11. 11.
    Bisno AL, Dismukes WE, Durack DT, et al. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci and staphylococci. JAMA 1989; 261: 1471–7PubMedCrossRefGoogle Scholar
  12. 12.
    Nelson JD, Bucholz RW, Kusmiesz H, et al. Benefits and risks of sequential parenteral-oral cephalosporin therapy for suppurative bone and joint infections. J Pediatr Orthop 1982; 2: 255–62PubMedCrossRefGoogle Scholar
  13. 13.
    Eisenberg JM, Kitz DS. Savings from outpatient antibiotic therapy for osteomyelitis. JAMA 1986; 255: 1584–8PubMedCrossRefGoogle Scholar
  14. 14.
    Schutze GE, Jacobs RF. Management of community-acquired bacterial pneumonia in hospitalized children. Pediatr Infect Dis J 1992; 11: 160–4PubMedCrossRefGoogle Scholar
  15. 15.
    Gadomski AM. Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections. Pediatr Infect Dis J 1993; 12: 115–20PubMedCrossRefGoogle Scholar
  16. 16.
    Bahal N, Nahata MC. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin and roxithromycin. Ann Pharmacother 1992; 26: 46–55PubMedGoogle Scholar

Copyright information

© Adis International Limited 1997

Personalised recommendations